Early-onset Parkinson disease

Gene: AFG3L2

Amber List (moderate evidence)

AFG3L2 (AFG3 like matrix AAA peptidase subunit 2)
EnsemblGeneIds (GRCh38): ENSG00000141385
EnsemblGeneIds (GRCh37): ENSG00000141385
OMIM: 604581, Gene2Phenotype
AFG3L2 is in 15 panels

3 reviews

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

I don't know

Two case reports with parkinsonism.
Created: 22 Sep 2022, 8:15 a.m. | Last Modified: 22 Sep 2022, 8:15 a.m.
Panel Version: 0.232

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Spinocerebellar ataxia 28, MIM# 610246

Shekeeb Mohammad (Children's Hospital at Westmead)

Green List (high evidence)

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Phenotypes
dystonia; parkinsonism; intellectual disability; optic hypoplasia; cognitive decline; dementia

Publications

Variants in this GENE are reported as part of current diagnostic practice

Bryony Thompson (Royal Melbourne Hospital)

Red List (low evidence)

Single case reported with parkinsonism, which also had a intragenic SPG7 deletion. Parkinsonism does not appear to be a prominent feature of AFG3L2-related disorders.
Created: 24 Mar 2020, 8:58 p.m. | Last Modified: 24 Mar 2020, 8:58 p.m.
Panel Version: 0.7

Mode of inheritance
Unknown

Phenotypes
optic atrophy; spastic ataxia; L-dopa-responsive parkinsonism

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Amber
  • Melbourne Genomics Health Alliance Complex Neurology Flagship
  • Victorian Clinical Genetics Services
Phenotypes
  • Spinocerebellar ataxia 28, MIM# 610246
  • optic atrophy
  • spastic ataxia
  • L-dopa-responsive parkinsonism
OMIM
604581
Clinvar variants
Variants in AFG3L2
Penetrance
None
Publications
Panels with this gene

History Filter Activity

22 Sep 2022, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: AFG3L2 were changed from to Spinocerebellar ataxia 28, MIM# 610246; optic atrophy; spastic ataxia; L-dopa-responsive parkinsonism

22 Sep 2022, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: AFG3L2 were set to

22 Sep 2022, Gel status: 2

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of inheritance for gene: AFG3L2 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

22 Sep 2022, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: afg3l2 has been classified as Amber List (Moderate Evidence).

22 Sep 2022, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: afg3l2 has been classified as Amber List (Moderate Evidence).

24 Mar 2020, Gel status: 1

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: afg3l2 has been classified as Red List (Low Evidence).

24 Mar 2020, Gel status: 1

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: afg3l2 has been classified as Red List (Low Evidence).

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: AFG3L2 was added gene: AFG3L2 was added to Early onset Parkinson disease_MelbourneGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Complex Neurology Flagship Mode of inheritance for gene: AFG3L2 was set to Unknown